Home  |  Contact

UniProtKB/Swiss-Prot Q9Y616: Variant p.Leu400Val

Interleukin-1 receptor-associated kinase 3
Gene: IRAK3
Variant information

Variant position:  400
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LB/B
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Leucine (L) to Valine (V) at position 400 (L400V, p.Leu400Val).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Similar physico-chemical property. Both residues are medium size and hydrophobic.
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  May be associated with ASRT5.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  400
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  596
The length of the canonical sequence.

Location on the sequence:   HIQLRDLLRELMEKRGLDSC  L SFLDKKVPPCPRNFSAKLFC
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         HIQLRDLLRELMEKRGLDSCLSFLDKKVPPCPRNFSAKLFC

Mouse                         HVQLRDLLMELMEKRGLDSCLSFLDRKIPPCPRNFSAKLFS

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 596 Interleukin-1 receptor-associated kinase 3
Domain 165 – 452 Protein kinase
Helix 396 – 402


Literature citations

IRAK-M is involved in the pathogenesis of early-onset persistent asthma.
Balaci L.; Spada M.C.; Olla N.; Sole G.; Loddo L.; Anedda F.; Naitza S.; Zuncheddu M.A.; Maschio A.; Altea D.; Uda M.; Pilia S.; Sanna S.; Masala M.; Crisponi L.; Fattori M.; Devoto M.; Doratiotto S.; Rassu S.; Mereu S.; Giua E.; Cadeddu N.G.; Atzeni R.; Pelosi U.; Corrias A.; Perra R.; Torrazza P.L.; Pirina P.; Ginesu F.; Marcias S.; Schintu M.G.; Del Giacco G.S.; Manconi P.E.; Malerba G.; Bisognin A.; Trabetti E.; Boner A.; Pescollderungg L.; Pignatti P.F.; Schlessinger D.; Cao A.; Pilia G.;
Am. J. Hum. Genet. 80:1103-1114(2007)
Cited for: INVOLVEMENT IN ASRT5; VARIANTS LEU-22; ALA-111; MET-134; VAL-400 AND GLN-429;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.